February 03rd, 2024

On Monday, February 5, a lineup of companies is poised to disclose their financial performance, featuring: McDonald's Corporation (NYSE: MCD), the global fast-food giant, is poised to announce its fourth-quarter 2023 financial results before the m. Read more

January 21st, 2024

On Tuesday, January 23, a trio of influential companies is poised to disclose their financial results: Netflix, Inc. (Nasdaq: NFLX), the streaming giant, will unveil its fourth-quarter 2023 financial results and provide insights into its business . Read more

November 04th, 2023

On Monday, November 6, several notable companies are set to disclose their financial reports, including: Ryanair Holdings plc (Nasdaq: RYAAY), a leading international airline, is poised to reveal its second-quarter and first-half fiscal 2024 finan. Read more

October 21st, 2023

On Tuesday, October 24, several major companies are scheduled to release their financial results, including: Alphabet Inc. (Nasdaq: GOOG) (Nasdaq: GOOGL), the parent company of Google, is set to unveil its financial performance for the third quart. Read more

August 16th, 2023

Raytheon Land & Air Defense Systems, a subsidiary of RTX Corporation (NYSE: RTX), was awarded a significant  fixed-price-incentive contract worth $322.5 million for the procurement of Tube-Launched, Optically-Tracked, Wireless-Guided 2B Missiles. Read more

August 09th, 2023

Shares of Galera Therapeutics, Inc.? (Nasdaq: GRTX) plunged over 70% in after-hours trading as the company received a Complete Response Letter (CRL) from the FDA, addressing its New Drug Application (NDA) for avasopasem manganese, a potential treatme. Read more

July 21st, 2023

Mirati Therapeutics, Inc. (Nasdaq: MRTX) faced a setback when the European Medicine Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) issued a negative opinion on the Conditional Marketing Authorisation Application (MAA) for its dr. Read more

July 01st, 2023

RTX (NYSE: RTX), through its subsidiaries, has been awarded three contracts totaling $5,623,670,040. The first one, awarded to RTX's Pratt & Whitney, is a modification worth $5,500,316,404 to the F117 Engine Sustainment Support contract, bringing . Read more

June 28th, 2023

Biopharmaceutical leader Gilead Sciences, Inc. (Nasdaq: GILD) has disclosed its acquisition of 2,930,870 shares of AlloVir, Inc. (Nasdaq: ALVR), a late clinical-stage cell therapy company, in a regulatory filing FORM 4 with the SEC. The shares were a. Read more

June 20th, 2023

Raytheon Missiles & Defense, a business segment of RTX (NYSE: RTX), has been awarded a significant contract worth $1,151,111,454 for the production of Advanced Medium Range Air-to-Air Missiles (AMRAAM). The contract also includes the provision of AMR. Read more

June 18th, 2023

Raytheon Technologies Corporation (NYSE: RTX), a leading aerospace and defense company, has announced its strategic plans to evolve from "Raytheon Technologies" to "RTX" as part of its portfolio realignment. This transition will focus on strengthenin. Read more

June 12th, 2023

Pratt and Whitney Military Engines, a Raytheon Technologies (NYSE: RTX) business, has been awarded a significant modification to a contract for the procurement of F-135 propulsion system spare parts and support equipment.  The firm-fixed-pric. Read more

June 09th, 2023

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics AG (Nasdaq: CRSP) have announced positive results from pivotal trials for their investigational treatment, exagamglogene autotemcel (exa-cel), in patients with transfusion-dep. Read more

June 08th, 2023

Raytheon Intelligence & Space, a key business segment of Raytheon Technologies Corp. (NYSE: RTX), has been awarded a significant contract worth $372,137,000 by the Naval Air Warfare Center Weapons Division.  The contract entails updates, impr. Read more

June 05th, 2023

Raytheon Technologies Corporation (NYSE: RTX), doing business as Pratt and Whitney Military Engines, has been awarded a significant contract modification worth $2,023,073,136.  The modification, designated as P00015, is an extension of a prev. Read more